Lucy Day
Fortune : 159 076 $ au 31/05/2026
Fortune : 159 076 $ au 31/05/2026
Lucy O.
Day is currently Chief Financial Officer at AN2 Therapeutics, Inc. since 2019.
Formerly, Ms. Day was Vice President at Bank of America Corp.
from 1990 to 1994, Chief Financial Officer at Centaur Pharmaceuticals, Inc. from 1994 to 2002, and CFO, VP-Human Resources & Finance at Anacor Pharmaceuticals LLC from 2002 to 2016.
Education includes undergraduate studies at the University of California, Berkeley.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 36 738 ( 0,1% ) | 159 076 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Directeur Financier/CFO | 01/08/2016 |
Centaur Pharmaceuticals, Inc.
Centaur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Financier/CFO | 01/01/2002 |
| BANK OF AMERICA CORPORATION | Corporate Officer/Principal | 01/01/1994 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Bank of America Corp.
Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
Centaur Pharmaceuticals, Inc.
Centaur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national